Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record now includes related topics tags for Schizophrenia and MedlinePlus Genetics. These tags connect the trial to broader educational resources about the condition and genetics, helping with discoverability.
    Difference
    0.1%
    Check dated 2026-05-10T09:27:08.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating an interface or release version change without modifying the study information.
    Difference
    0.0%
    Check dated 2026-04-25T18:44:07.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Schizophrenia, related topics: MedlinePlus Genetics, and Revision: v3.5.0.
    Difference
    0.2%
    Check dated 2026-04-18T13:27:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Related topics Schizophrenia and MedlinePlus Genetics were added to the study page to provide broader context and improve discoverability.
    Difference
    0.1%
    Check dated 2026-04-11T10:32:09.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Removed the Schizophrenia topic tag and related topics including MedlinePlus Genetics from the page; this affects navigation tags but does not alter the core trial content.
    Difference
    0.1%
    Check dated 2026-04-04T05:46:02.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Sponsor information was updated to include Karuna Therapeutics, Inc., a Bristol Myers Squibb company, and schizophrenia- and MedlinePlus Genetics-related topics were added. The standalone term Karuna Therapeutics was removed.
    Difference
    0.3%
    Check dated 2026-03-27T22:35:59.000Z thumbnail image

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.